Login to Your Account



Other News To Note


Wednesday, January 2, 2013

• K-V Pharmaceutical Co., of St. Louis, said the U.S. Bankruptcy Court for the Southern District of New York approved its settlement agreement with Hologic Inc., of Bedford, Mass., and authorized the company to enter into an $85 million debtor-in-possession (DIP) financing to fund the settlement and other business matters.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription